ChemicalBook > CAS DataBase List > CI 934

CI 934

Product Name
CI 934
CAS No.
91188-00-0
Chemical Name
CI 934
Synonyms
CI 934;PD-114843;Aids007688;Aids-007688;Quinolone cl-934;Merafloxacin (CI-934);Merafloxacin, 10 mM in DMSO;1-Ethyl-7-(3-((ethylamino)methyl)pyrrolidin-1-yl)-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;1-Ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid;3-Quinolinecarboxylic acid, 1-ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4-dihydro-4-oxo-
CBNumber
CB91398664
Molecular Formula
C19H23F2N3O3
Formula Weight
379.4
MOL File
91188-00-0.mol
More
Less

CI 934 Property

Melting point:
200-220.45 °C
Boiling point:
545.8±50.0 °C(Predicted)
Density 
1.304±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO : 11.11 mg/mL (29.28 mM; ultrasonic and adjust pH to 3 with HCl)
form 
Solid
pka
6.44±0.50(Predicted)
color 
White to off-white
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Adipogen Life Sciences
Product number
AG-CR1-3756-M005
Product name
Merafloxacin
Purity
≥95%
Packaging
5mg
Price
$80
Updated
2021/12/16
More
Less

CI 934 Chemical Properties,Usage,Production

Uses

Merafloxacin (CI-934), a fluoroquinolone antibacterial agent, is a selective programmed -1 ribosomal frameshifting (-1 PRF) inhibitor of beta coronaviruses. Merafloxacin exhibits in vitro activity against gram-positive and gram-negative bacteria[1][2].

Biological Activity

Merafloxacin (CI-934), a fluoroquinolone antibacterial agent, is a selective programmed -1 ribosomal frameshifting (-1 PRF) inhibitor of beta coronaviruses. Merafloxacin exhibits in vitro activity against gram-positive and gram-negative bacteria[1][2]. Merafloxacin (5-80 μM) dose-dependently inhibits programmed -1 ribosomal frameshifting (-1 PRF) of SARS-CoV-2, SARS-CoV, hCoVO-C43, and hCoV-HKU1, with IC50s of 19.6 μM, 19.5 μM, 29.7 μM, and 38.6 μM, respectively[1].

References

[1]. Sun Y, et, al. Restriction of SARS-CoV-2 Replication by Targeting Programmed -1 Ribosomal Frameshifting In Vitro. bioRxiv. 2020 Oct 21;2020.10.21.349225. [2]. Mandell W, et, al. In vitro activity of CI-934, a new quinolone, compared with that of other quinolones and other antimicrobial agents. Antimicrob Agents Chemother. 1986 May;29(5):852-7.

CI 934 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

CI 934 Suppliers

TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58
Aladdin Scientific
Tel
Email
tp@aladdinsci.com
Country
United States
ProdList
52923
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354;
Email
support@targetmol.com
Country
United States
ProdList
39035
Advantage
58

91188-00-0, CI 934Related Search:


  • CI 934
  • 1-Ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
  • PD-114843
  • Aids007688
  • Aids-007688
  • Quinolone cl-934
  • 3-Quinolinecarboxylic acid, 1-ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4-dihydro-4-oxo-
  • Merafloxacin (CI-934)
  • Merafloxacin,frameshifting,SARS-CoV,bacteria,antibacterial,fluoroquinolone,Inhibitor,CI934,gram-positive,inhibit,programmed,coronaviruses,ribosomal,PRF,gram-negative,SARS coronavirus,CI-934
  • 1-Ethyl-7-(3-((ethylamino)methyl)pyrrolidin-1-yl)-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
  • Merafloxacin, 10 mM in DMSO
  • 91188-00-0